WSJ doesn't disclose Galen Institute's reported industry ties in president's health care op-ed
The Wall Street Journal published an op-ed co-written by Galen Institute president Grace-Marie Turner promoting congressional Republicans' health care reform proposal without noting that the Galen Institute reportedly receives funding from the pharmaceutical and medical industries.
On May 20, The Wall Street Journal published an op-ed  by Galen Institute  president Grace-Marie Turner and American Enterprise Institute scholar Joseph Antos promoting congressional Republicans' health care proposal  as "a clear alternative to the health-reform plans being developed by the White House and Democrats in Congress." However, the Journal did not disclose that the Galen Institute reportedly receives funding from the pharmaceutical and medical industries, which obviously have an interest in the outcome of Congress' health care reform deliberations.
As Media Matters for America has noted , in biographical information accompanying a May 11 opinion piece  (registration required) written by Turner, McClatchy-Tribune Media Services noted that Galen is "funded in part by the pharmaceutical and medical industries." Unlike the Journal, which noted only that Turner is "president of the Galen Institute," McClatchy-Tribune regularly  discloses  Turner's ties to those industries in biographical notes accompanying her op-eds.